TETs, which include thymoma, thymic carcinoma, and neuroendocrine tumors, are rare thoracic cancers that occur with an incidence of 2-3 cases per million people per year.1 Arising from the epithelium of the thymus, these tumors are associated with paraneoplastic syndromes in 30%-40% of thymoma cases and up to 5% of thymic carcinoma cases, with myasthenia gravis the most common complication.2,3 Surgery is a cornerstone of treatment across many clinical practice guidelines.4-6 For patients with...
